Lonza Capsules and Health Ingredients launches aromatic coating technology for capsules
Lonza explains that the technology utilizes naturally-derived essential oils such as peppermint and orange to create a multi-sensory supplement experience for consumers.
Photo © AdobeStock.com/Andrey Popov
Lonza Capsules and Health Ingredients has announced the launch of AromatiQ technology, which is an aroma capsule coating technology. Lonza explains that the technology utilizes naturally-derived essential oils such as peppermint and orange to create a multi-sensory supplement experience for consumers.
According to research from Lonza, 70% of consumers would pay more for a more enjoyable and memorable supplement experience. The company portfolio of essential oils and aroma coatings can be matched to intended health benefits. Citrus essential oils would be a good match for mood support supplements, for example, while peppermint is more associated with focus and vitality. The aromatic coating also help mask strong-smelling ingredients such as ashwagandha and valerian root, Lonza explains.
To learn more about AromatiQ, Lonza will be at Vitafoods Europe 2024 at booth #G90.
Magnesium L-threonate, Magtein, earns novel food authorization in the European Union
December 19th 2024According to the announcement, the authorization is also exclusive to AIDP and its partner company and licensee, ThreoTech, meaning that they are the only parties that can market magnesium L-threonate in the EU for a period of five years.
Survey finds a lack of enthusiasm about AI technology among food and beverage consumers
December 12th 2024The survey, commissioned by Ingredient Communications and conducted by SurveyGoo, found that 83% of respondent agreed that companies should declare on product labels when a product has been designed or manufactured with the assistance of AI technology.
Kelker Pharma to launch nutritional support system for GLP-1 medication users that features TriBsyn
December 11th 2024B&D Nutritional Ingredients Inc., an exclusive distribution partner of CarnoSyn Brands and Natural Alternatives International Inc., announced that its customer, Kelker Pharma, will be launching the “first science-backed nutritional support system” for GLP-1 medication users, called Nutrilinq Genesis.
